Global Cancer Biomarkers Market 2017-2025 - CAGR to Grow by 11.5% - ResearchAndMarkets.com

DUBLIN--()--The "Global Cancer Biomarkers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to ResearchAndMarkets.com's offering.

The cancer biomarkers market was valued at USD 10,514 million in 2016, and is expected to reach USD 30,284.5 million by 2025, expanding at a CAGR of 11.5% from 2017 to 2025.

The overall market segmentation of cancer biomarkers market comprises by type, cancer type, profiling technologies type, and application type.

In year 2016, proteomic biomarkers dominated the market by type due to exceptional market potential of protein biomarkers in diagnostics, prognostics, cancer detection and other clinical & therapeutic applications. In addition, increasing focus of pharmaceutical & biotechnology companies in research and development of protein biomarkers is expected to fuel the overall market growth.

Key Market Movements:

  • Rising prevalence of cancer in developed as well as developing countries
  • Increasing application of biomarkers in the drug discovery and development process
  • Supportive government policies and awareness activities carried out by non-government organization

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Cancer Biomarkers Market: Market Dynamics and Future Outlook

Chapter 4. Global Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)

Chapter 5. Global Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)

Chapter 6. Global Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)

Chapter 7. Global Cancer Biomarkers Market, by Type of Application, 2015 - 2025 (US$ Mn)

Chapter 8. Global Cancer Biomarkers Market, by Geography, 2015 - 2025 (US$ Mn)

Chapter 9. Company Profiles

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Hologic, Inc.
  • Illumina, Inc.
  • Merck & Co. Inc.
  • Qiagen N.V.
  • Quest Diagnostics Inc.
  • Roche Diagnostics Ltd.
  • Sino Biological Inc.

For more information about this report visit https://www.researchandmarkets.com/research/22hkl9/global_cancer?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomarkers

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomarkers